Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-23-036239
Filing Date
2023-03-24
Accepted
2023-03-24 06:50:48
Documents
73
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K lptx-20221231x10k.htm   iXBRL 10-K 1761533
2 EXHIBIT 21.1 lptx-20221231xex21d1.htm EX-21.1 8853
3 EXHIBIT 23.1 lptx-20221231xex23d1.htm EX-23.1 2831
4 EXHIBIT 31.1 lptx-20221231xex31d1.htm EX-31.1 17587
5 EXHIBIT 32.1 lptx-20221231xex32d1.htm EX-32.1 12982
  Complete submission text file 0001104659-23-036239.txt   7290162

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA lptx-20221231.xsd EX-101.SCH 47511
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lptx-20221231_cal.xml EX-101.CAL 53124
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lptx-20221231_def.xml EX-101.DEF 174231
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20221231_lab.xml EX-101.LAB 500117
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20221231_pre.xml EX-101.PRE 342156
67 EXTRACTED XBRL INSTANCE DOCUMENT lptx-20221231x10k_htm.xml XML 1172667
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37990 | Film No.: 23757619
SIC: 2834 Pharmaceutical Preparations